Cannabis stocks were higher Monday, as investors reacted to the latest tie-ups in the sector and awaited the release of quarterly earnings from Tilray Inc. after the close.
Analysts polled by FactSet expect losses of 15 cents a share. The company was not yet public in the year-prior quarter and no data is available. In the third quarter, Tilray reported losses of 20 cents a share. Tilray is expected to report revenue of $15.9 million. The company reported third-quarter sales of $10 million.Massachusetts-based, multistate cannabis operator Curaleaf Holdings Inc.’s shares CURLF, +8.
The PRV program aims to encourage companies to invest in R&D for rare pediatric diseases. The buyer is entitled to a priority, expedited review, with the aim of helping to bring drugs to market that treat rare diseases. In regulatory news, former U.S. House Speaker John Boehner, a longtime cannabis critic who surprised investors last year when he announced he was joining the board of cannabis company Acreage Holdings and said his thinking on the subject had changed, said the U.S. government should get on board with legalization.
chernandburn Except for LHSIF ☹️